|
|
||||||||
Departments of 1Pharmacology and Toxicology, 2Pediatrics 3Biochemistry and Molecular Biology, and 4Core Proteomics Laboratory, Kidney Disease Program, Department of Medicine, University of Louisville, Louisville 40202; 5Veterans Affairs Medical Center, Louisville, Kentucky 40206; and 6Medical Molecular Biology Unit, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Submitted 2 February 2004 ; accepted in final form 16 July 2004
Diabetic cardiomyopathy is a common complication leading to heightened risk of heart failure and death. In the present report, we performed proteomic analysis on total cardiac proteins from the OVE26 mouse model of type 1 diabetes to identify protein changes that may contribute to diabetic cardiomyopathy. This analysis revealed that a surprising high proportion (12 of 20) of the altered proteins that could be identified by mass spectrometry were of mitochondrial origin. All but one of these proteins were upregulated by diabetes. Quantitative RT-PCR, performed for two of these proteins, indicated that part of the upregulation was attributed to increased messenger RNA levels. Morphological study of diabetic hearts showed significantly increased mitochondrial area and number as well as focal regions with severe damage to mitochondria. Diabetic mitochondria also showed reduced respiratory control ratio (9.63 ± 0.20 vs. 6.13 ± 0.41, P < 0.0001), apparently due to reduced state 3 rate, and diminished GSH level (5.5 ± 0.9 vs. 8.2 ± 2.5 µmol/mg protein, P < 0.05), indicating impaired mitochondrial function and increased oxidative stress. Further examination revealed increased mitochondrial DNA (1.03 ± 0.18 vs. 0.69 ± 0.13 relative copy number, P < 0.001) and a tendency to higher protein yield in OVE26 cardiac mitochondria, as well as increased mRNA level for mitochondrial transcription factor A and two mitochondrial encoded proteins. Taken together, these results show that mitochondria are a primary target in the diabetic heart, probably due to oxidative stress, and that this damage coincides with and may stimulate mitochondrial biogenesis.
heart; mitochondria; proteomics; oxidative stress
This article has been cited by other articles:
![]() |
L. Liu, X. Shi, C. S. Choi, G. I. Shulman, K. Klaus, K. S. Nair, G. J. Schwartz, Y. Zhang, I. J. Goldberg, and Y.-H. Yu Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1 Diabetes, November 1, 2009; 58(11): 2516 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, Q. Gong, J. P. Stice, and A. A. Knowlton Mitochondrial OPA1, apoptosis, and heart failure Cardiovasc Res, October 1, 2009; 84(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bugger and E. D. Abel Rodent models of diabetic cardiomyopathy Dis. Model. Mech., September 1, 2009; 2(9-10): 454 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bugger, D. Chen, C. Riehle, J. Soto, H. A. Theobald, X. X. Hu, B. Ganesan, B. C. Weimer, and E. D. Abel Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice Diabetes, September 1, 2009; 58(9): 1986 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boudina, H. Bugger, S. Sena, B. T. O'Neill, V. G. Zaha, O. Ilkun, J. J. Wright, P. K. Mazumder, E. Palfreyman, T. J. Tidwell, et al. Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart Circulation, March 10, 2009; 119(9): 1272 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Johnson, R. A. Harris, S. French, A. Aponte, and R. S. Balaban Proteomic changes associated with diabetes in the BB-DP rat Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E422 - E432. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, L. Ebermann, A. Sterner-Kock, S. Wika, H.-P. Schultheiss, A. Dörner, and T. Walther Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice Exp Physiol, February 1, 2009; 94(2): 220 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Dabkowski, C. L. Williamson, V. C. Bukowski, R. S. Chapman, S. S. Leonard, C. J. Peer, P. S. Callery, and J. M. Hollander Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H359 - H369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Argyropoulos, A. M. Stutz, O. Ilnytska, T. Rice, M. Teran-Garcia, D. C. Rao, C. Bouchard, and T. Rankinen KIF5B gene sequence variation and response of cardiac stroke volume to regular exercise Physiol Genomics, January 8, 2009; 36(2): 79 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suarez, Y. Hu, A. Makino, E. Fricovsky, H. Wang, and W. H. Dillmann Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1561 - C1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boudina, S. Sena, H. Theobald, X. Sheng, J. J. Wright, X. X. Hu, S. Aziz, J. I. Johnson, H. Bugger, V. G. Zaha, et al. Mitochondrial Energetics in the Heart in Obesity-Related Diabetes: Direct Evidence for Increased Uncoupled Respiration and Activation of Uncoupling Proteins Diabetes, October 1, 2007; 56(10): 2457 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Alcolea, I. Llado, F. J. Garcia-Palmer, and M. Gianotti Responses of mitochondrial biogenesis and function to maternal diabetes in rat embryo during the placentation period Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E636 - E644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boudina and E. D. Abel Diabetic Cardiomyopathy Revisited Circulation, June 26, 2007; 115(25): 3213 - 3223. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al. Recipes for Creating Animal Models of Diabetic Cardiovascular Disease Circ. Res., May 25, 2007; 100(10): 1415 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome? Circ. Res., March 30, 2007; 100(6): 795 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Duncan, J. L. Fong, D. M. Medeiros, B. N. Finck, and D. P. Kelly Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-{alpha}/PGC-1{alpha} Gene Regulatory Pathway Circulation, February 20, 2007; 115(7): 909 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Lai, T.-J. Liu, C.-T. Ting, J.-Y. Yang, L. Huang, D. Wallace, P. Kaiser, and P. H. Wang Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60 Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E292 - E297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boudina and E. D. Abel Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology, August 1, 2006; 21: 250 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Di Noia, S. Van Driesche, F. Palmieri, L.-M. Yang, S. Quan, A. I. Goodman, and N. G. Abraham Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental Diabetes J. Biol. Chem., June 9, 2006; 281(23): 15687 - 15693. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shen, S. Zheng, N. S. Metreveli, and P. N. Epstein Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy Diabetes, March 1, 2006; 55(3): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghosh, T. Pulinilkunnil, G. Yuen, G. Kewalramani, D. An, D. Qi, A. Abrahani, and B. Rodrigues Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H768 - H776. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Scott, A. M Carter, and J. B. Findlay The application of proteomics to diabetes Diabetes and Vascular Disease Research, May 1, 2005; 2(2): 54 - 60. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |